Postcystectomy radiotherapy has not been analyzed profoundly for several reasons: the local recurrence rate is low; it has been used exclusively preoperatively since the first cooperative clinical trials were conducted; a high incidence of intestinal obstruction has been reported. The tumors that can benefit from coadjuvant radiotherapy, particularly those with a higher risk of local recurrence, are analyzed.